NOELLE BERARDI: Open Payments
NPI 1619659240 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 14 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $189 |
| GlaxoSmithKline, LLC. | 4 | $176 |
| Regeneron Healthcare Solutions, Inc. | 5 | $166 |
| GENZYME CORPORATION | 2 | $75 |
Products named: DUPIXENT, Xhance, NUCALA.
Industry payments across VA — which companies pay providers there.
